pharmaceutical-investing Foamix Reports First Quarter 2018 Financial Results and Provides Corporate Update
pharmaceutical-investing VBL Therapeutics Announces Top-Line Results from Pivotal Phase 3 GLOBE Study
pharmaceutical-investing Melinta Therapeutics Publishes Complete Results from Phase 3 TANGO I Study of VABOMERE
pharmaceutical-investing Intercept Announces Phase 3 REVERSE Trial Evaluating OCA for the Treatment of NASH Patients
SAGA Metals Announces Additional Assay Results from Drilling at Trapper North, Confirming High-Grade Mineralization at Radar Critical Minerals Project in Labrador
Providence Gold Mines Inc. Announces Final Approval of Reviewable Transaction and The La Dama de Oro Gold Property NI43 101 Report
